Physician

Michelle Gita Baechtold, MD

According to 2025 Medicare claims, Michelle Baechtold, MD (NPI: 1669867669) practices dermatology in the Bloomington, IN market, with the plurality of this provider's patient population coming from Monroe, IN. This provider's primary affiliated billing organization is DERMATOLOGY CENTER OF SOUTHERN INDIANA, P.C. (NPI: 1659451755; TIN: 35-1333192) and primary practice location at 47403-4792.

Baechtold's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,197 traditional Medicare patients, billed 10,657 HCPCS/CPT codes, and received $445,575 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,664 prescription claims across 637 beneficiaries totaling $774,941 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 74 records totaling $1,493. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $58,901 and ending at $445,575. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,071 to $774,941. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$223K$446K2019 Medicare payment: $58,901 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $264,926 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $332,859 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $295,893 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $194,709 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $445,575 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20193471,747$58,901
20209619,701$264,926
20211,02912,686$332,859
20221,09611,848$295,893
20239867,744$194,709
20241,19710,657$445,575

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$387K$775K2015 Drug cost: $4,071 (USD; Tot_Drug_Cst)2016 Drug cost: $11,971 (USD; Tot_Drug_Cst)2019 Drug cost: $20,457 (USD; Tot_Drug_Cst)2020 Drug cost: $97,067 (USD; Tot_Drug_Cst)2021 Drug cost: $161,929 (USD; Tot_Drug_Cst)2022 Drug cost: $338,488 (USD; Tot_Drug_Cst)2023 Drug cost: $677,130 (USD; Tot_Drug_Cst)2024 Drug cost: $774,941 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152475$4,071
201646235$11,971
2017N/RN/RN/R
2018N/RN/RN/R
2019100179$20,457
20204101,017$97,067
20214921,319$161,929
20225111,384$338,488
20234371,226$677,130
20246371,664$774,941

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more220271$79
11102Biopsy of related skin growth, first growth399460$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more9551,221$57
17000Destruction of precancer skin growth, 1 growth684871$35
17003Destruction of precancer skin growth, 2-14 growths5673,525$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab421,162$155,431
KetoconazoleKetoconazole44514,123$8,929
Clobetasol PropionateClobetasol Propionate972,986$7,111
TacrolimusTacrolimus341,113$4,806
MetronidazoleMetronidazole421,382$2,827

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.74$1,493Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michelle Gita Baechtold, MD?

Tedicare shows public-source Medicare data for Michelle Gita Baechtold, MD (NPI 1669867669), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michelle Gita Baechtold, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michelle Gita Baechtold, MD?

Michelle Gita Baechtold, MD is linked to DERMATOLOGY CENTER OF SOUTHERN INDIANA, P.C. (billing NPI 1659451755) in the available physician profile data.

Does Michelle Gita Baechtold, MD have Open Payments data?

Michelle Gita Baechtold, MD has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.